Research
1,493 papers- Preclinical Evaluation of Bavdegalutamide (ARV-110), a Novel PROteolysis TArgeting Chimera Androgen Receptor Degrader.Molecular cancer therapeutics · 2025
- Bridged Proteolysis Targeting Chimera (PROTAC) Enables Degradation of Undruggable Targets.Journal of the American Chemical Society · 2022
- PROteolysis TArgeting Chimera (PROTAC) Estrogen Receptor Degraders for Treatment of Estrogen Receptor-Positive Advanced Breast Cancer.Targeted oncology · 2025
- Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors.Communications biology · 2024
- Proteolysis Targeting Chimera (PROTACs) in Cancer: From Molecular Mechanisms to Therapeutic Opportunities.Journal of biochemical and molecular toxicology · 2025
via PubMed
Wikidata facts
- Subclass of
- chemical compound
- Image
- How PROTACs Use Our Cells' Natural Disposal System to Kill Cancer-Causing Proteins.jpg
Show 1 more fact
- Commons category
- Proteolysis targeting chimera
via Wikidata · CC0